Pivekimab
immunogen
['pivotal', 'immunogen']
#teamimmunogen is in vienna for #eha22 to hear from industry experts discussing the latest advances and news in hematology, while getting a chance to showcase our own trial in progress poster from our pivotal phase 2 #cadenza study of #pivekimab sunirine in #bpdcn! 
We exist to interrupt the progress of cancer so cancer can't interrupt the lives of our patients. #TargetABetterNow

Policy: https://t.co/MLtPQiuFPo